Reappraisal of the clinical effect of mepolizumab - Authors' reply.

Chupp, Geoffrey L; Bradford, Eric S; Albers, Frank C; Bratton, Daniel J; Wang-Jairaj, Jie; Nelsen, Linda M; Trevor, Jennifer L; Magnan, Antoine

Chupp, Geoffrey L; Bradford, Eric S; Albers, Frank C; Bratton, Daniel J; Wang-Jairaj, Jie; Nelsen, Linda M; Trevor, Jennifer L; Magnan, Antoine.

Afiliação

Chupp GL; Yale Center for Asthma and Airways Disease, Yale School of Medicine, New Haven, CT 06520-8057, USA. Electronic address: geoffrey.chupp@yale.edu.
Bradford ES; Respiratory Therapeutic Area, GlaxoSmithKline (GSK), Research Triangle Park, NC, USA.
Albers FC; Respiratory Medical Franchise, GlaxoSmithKline (GSK), Research Triangle Park, NC, USA.
Bratton DJ; Clinical Statistics, GSK, Stockley Park, Middlesex, UK.
Wang-Jairaj J; Respiratory Therapy Area, GSK, Stockley Park, Middlesex, UK.
Nelsen LM; Value Evidence and Outcomes, GSK, Collegeville, PA, USA.
Trevor JL; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Magnan A; l'Institut du Thorax, Universite de Nantes, CHU de Nantes, Nantes, France.

Lancet Respir Med ; 5(6): e21, 2017 06.

Article em En | MEDLINE | ID: mdl-28664853

Assuntos

Anticorpos Monoclonais Humanizados; Eosinófilos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinófilos / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Revista: Lancet Respir Med Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google